Table of Contents
- 9 Questions Buyers and Investors Ask When IP Is a Core Asset
- 1. Does The Company Actually Own The IP It Says It Owns?
- 2. Are The Registrations Valid, Current, And In Good Standing?
- 3. Who Created The IP, And Did Everyone Assign Their Rights Properly?
- 4. Is Any Of The IP Encumbered By Liens, Security Interests, Or Other Claims?
- 5. Does The Company Have The Right To Use Everything In Its Product And Business?
- 6. Are Trade Secrets Actually Being Treated Like Trade Secrets?
- 7. Is There Any Pending, Threatened, Or Historical IP Dispute?
- 8. Could Any Rights Be Lost, Reclaimed, Or Limited Later?
- 9. How Material Is The IP To Revenue, Defensibility, And Deal Value?
- Why These Questions Matter More Than Founders Expect
- Final Thoughts
Type
Great Grandchild
Status
Approved
Caption
Title (YouTube)
Caption X
Cover
OG Image
Alt Image Text
Flat vector cover image showing investors reviewing patents, software, data, and confidential documents with magnifying glass, lock, folders, and checklist icons to represent IP due diligence and ownership verification.
Images
Videos
Video Published (Blog)
Publish Date (Social)
Oct 16, 2027 10:00
Scheduled (Social)
Scheduled (Social)
Images Posted (Social)
Images Failed (Social)
Videos Posted (Social)
Videos Failed (Social)
Featured
Do not index
Videos Post IDs (Social)
Created time
Apr 8, 2026 06:40 PM
Sub-item
Authors
Images Post IDs (Social)
YT Post ID
YT Embedded
Images Delete (Social)
Videos Delete (Social)
9 Questions Buyers and Investors Ask When IP Is a Core Asset
When a company’s value depends heavily on patents, trademarks, copyrights, software, data rights, or trade secrets, diligence usually turns into a very specific set of questions. Buyers and investors are not just asking whether the business “has IP.” They are asking whether the company actually owns it, controls it, can enforce it, and can keep using it after the deal closes.
That distinction matters. A patent that has lapsed, a trademark with a weak chain of title, a codebase built with unclear contractor assignments, or a trade secret that was never handled confidentially can change valuation, timelines, indemnity discussions, and sometimes the deal itself. The World Intellectual Property Organization’s guidance on IP diligence readiness frames the exercise in similarly practical terms: identify the assets, confirm ownership, and surface defects before the transaction gets expensive.
In this post you’ll learn the nine questions buyers and investors tend to ask when IP is a core asset, why those questions keep coming up, and where legal risk often hides. If you want a broader walkthrough of the process, it may help to start with this overview of how IP deal diligence typically works from ownership through encumbrances.
Scroll to the bottom for every post in this series.
1. Does The Company Actually Own The IP It Says It Owns?
This is usually the first question because almost every other diligence issue flows from it.
For patents and trademarks, buyers often look for a clean chain of title backed by signed assignments and recorded ownership updates. The USPTO’s Assignment Center exists for exactly this reason: parties can record transfers of patent and trademark ownership, and the public databases can then be searched to confirm recorded interests and ownership history. The USPTO also notes that maintaining a clear title to pending patent applications and patents depends on recording assignments and related documents with the agency’s Assignment Recordation Branch. See the USPTO’s patent assignment guidance here and trademark assignment guidance here.
In practice, buyers often compare:
- IP schedules in the data room
- issued registrations and pending applications
- founder, employee, and contractor invention-assignment documents
- asset purchase documents from prior deals
- USPTO or Copyright Office recordation data
For copyrights, the question often turns on whether the company obtained ownership in writing. The U.S. Copyright Office explains that a non-author organization can be named as claimant only if it obtained ownership of all rights in writing or by operation of law. Its recordation system is also used for transfers of copyright ownership and related documents. Those details matter for software companies, media businesses, and content-heavy startups. See the Copyright Office’s recordation overview here and claimant guidance here.
A surprising amount of deal friction comes from ordinary operational gaps: a founder formed the company after building the first version of the product, a contractor signed a services agreement but not an IP assignment, or an acquired subsidiary kept key filings in a legacy entity’s name. If you want to go deeper on this issue, it helps to read more about the ownership chain and other IP title issues that often shape deal risk.
2. Are The Registrations Valid, Current, And In Good Standing?
Owning an IP asset on paper is one thing. Having an asset that is still enforceable, current, and properly maintained is another.
For patents, buyers often verify whether the rights are actually in force. The USPTO explains that maintenance fees are required to keep most utility and reissue utility patents in force, generally at 3.5, 7.5, and 11.5 years after grant, and that failure to pay can cause the patent rights to lapse. The agency also publishes lists of patents that have expired for nonpayment. That can turn a supposedly core asset into a historical artifact very quickly. See the USPTO’s maintenance-fee guidance here and general management page here.
Trademark diligence often focuses on whether registrations are live, whether required maintenance filings were made, whether specimens and ownership details line up with actual use, and whether there are pending office actions, oppositions, or cancellation risk. Even a registered mark can create concern if the filing history suggests gaps in use or ownership inconsistencies.
For copyrights, registration status may matter less to ownership than it does to enforcement leverage and litigation posture. A buyer looking at a content library, SaaS platform, or design-heavy business may want to know which works are registered, which are merely claimed internally, and whether recordation history matches the company’s narrative.
This question is often less dramatic than a title dispute, but it regularly affects price discussions. Rights that are stale, abandoned, or administratively messy tend to get discounted.
3. Who Created The IP, And Did Everyone Assign Their Rights Properly?
This question sounds repetitive, but buyers often separate “formal ownership” from “creator-by-creator risk.”
Why? Because many IP problems begin at the creation stage:
- founders built the core tech before incorporation
- overseas developers worked through a staffing firm
- university personnel contributed to inventions
- consultants reused prior code or design assets
- departing employees retained copies of sensitive materials
For patent-related assets, the inventorship and assignment story can be especially important. A missing inventor, or an inventor who never actually assigned rights, can complicate enforcement and transactional certainty. For copyrights and software, the analysis often centers on work-made-for-hire language, backup assignments, and whether the contracting chain actually reached the people who wrote the code or created the content.
Trade secrets raise a related but slightly different issue. If the company’s know-how was developed by people who were never bound by confidentiality or invention-assignment obligations, a buyer may wonder whether the information was ever adequately protected in the first place.
The USPTO’s trade secret materials emphasize that trade secrets remain protected only if they are kept secret through reasonable efforts by the owner. See the USPTO’s trade secret toolkit here. That is one reason employee onboarding, contractor paperwork, repository access controls, and offboarding practices all show up in diligence.
When investors ask this question, they are often trying to measure something broader than legal formalities: how disciplined the company has been about protecting its core asset over time.
4. Is Any Of The IP Encumbered By Liens, Security Interests, Or Other Claims?
This is where many deals get more technical.
A company may “own” the IP and still have limited freedom to sell, pledge, license, or transfer it if the asset is subject to:
- secured lending arrangements
- blanket liens under credit facilities
- negative covenants
- prior exclusive licenses
- purchase-money interests
- bankruptcy-related claims
Recorded assignments at the USPTO do not always answer these questions by themselves. Buyers often look at UCC filings, debt documents, intercompany arrangements, and prior acquisition documents to understand whether anyone else has a claim on the assets or their proceeds.
This matters because an overlooked lien can delay closing, require payoff letters, trigger consent requirements, or create post-closing disputes over ownership and collateral release. In some transactions, the lien analysis is almost as important as the chain-of-title analysis.
This is one of the places where founders and smaller companies get surprised. A venture debt document or general security agreement may have swept in “all assets,” including IP, even when the company never thought of its patent portfolio or codebase as collateral in any practical sense.
If this part of the process feels abstract, this is also where a more detailed discussion of ownership, registrations, liens, and transaction risk in IP diligence can add context.
5. Does The Company Have The Right To Use Everything In Its Product And Business?
A company can own some IP and still depend heavily on IP it does not own.
That is why buyers and investors often ask:
- What third-party code is embedded in the product?
- What open-source software is being used, and under which licenses?
- Are there field-of-use, territory, sublicensing, or exclusivity limits?
- Do customer contracts restrict internal reuse of deliverables or models?
- Does any key technology depend on university, founder, or affiliate licenses?
This question often becomes a “freedom to operate” discussion at a practical level, even when a formal freedom-to-operate opinion is not part of the deal.
Licenses can be extremely valuable, but they can also be fragile. Some are non-assignable without consent. Some terminate automatically upon change of control. Some limit modifications, derivative works, or sublicensing. Some grant rights that are narrower than the business model requires.
Antitrust and competition issues can also enter the picture when IP licensing affects market behavior. The DOJ and FTC have long recognized that IP licensing is generally procompetitive, but licensing restrictions can still raise antitrust concerns depending on market context and competitive effects. See the DOJ’s Antitrust Guidelines for the Licensing of Intellectual Property and the Antitrust Division’s discussion of licensing variations and competitive concerns.
In deal terms, this question is really asking: If the transaction closes tomorrow, can the business keep operating exactly as represented?
6. Are Trade Secrets Actually Being Treated Like Trade Secrets?
For many companies, the most valuable IP is not registered at all. It is embedded in:
- source code and deployment processes
- pricing models and training data
- manufacturing methods
- customer lists and supplier terms
- product roadmaps
- internal research and technical know-how
That creates a diligence challenge. A patent can be looked up. A trademark registration can be searched. A trade secret depends on evidence of secrecy and control.
The USPTO describes trade secrets as information that derives value from not being generally known and is maintained as secret through reasonable efforts by the owner. See the USPTO’s trade secret resources here. NIST’s more general confidentiality guidance also reflects how central data protection and controlled access have become in protecting sensitive business information. See NIST’s publication on data confidentiality and breach response and its update on protecting sensitive information in nonfederal systems.
So buyers often ask:
- who has access to the secret information
- whether NDAs are consistently used
- how repositories and files are permissioned
- whether confidential information is segregated and labeled
- how employee departures are handled
- whether there have been leaks, breaches, or public disclosures
This issue has become even more visible as noncompete law has shifted. The FTC announced a nationwide noncompete rule in April 2024, but the agency also states that the rule is not in effect and not enforceable following a federal court order entered on August 20, 2024; the FTC later took steps in September 2025 to dismiss its appeal. The same FTC materials point to trade secret law and NDAs as established alternatives for protecting proprietary information. See the FTC announcement here.
For diligence, that backdrop often sharpens the question: if employee mobility is high, what practical systems protect the know-how?
7. Is There Any Pending, Threatened, Or Historical IP Dispute?
Buyers rarely want to discover after closing that the company’s core product is already the subject of a cease-and-desist campaign, inventorship fight, authorship dispute, open-source compliance issue, or trade secret claim.
This question often covers:
- pending infringement lawsuits
- PTAB, TTAB, opposition, or cancellation matters
- threatened claims and demand letters
- settlement agreements with ongoing obligations
- coexistence agreements
- former-employee disputes involving code or data
- indemnity obligations to customers or distributors
In some industries, sector-specific databases matter too. In life sciences, for example, buyers often look at Orange Book patent listings because the FDA publishes patent information submitted by NDA holders for approved brand-name drugs, while also making clear that the FDA does not enforce patents or evaluate their validity or infringement. See the FDA’s explanation here.
Even when a dispute has been settled, it may still affect value if it created field-of-use restrictions, payment obligations, admissions, monitoring terms, or limitations on future enforcement.
Investors asking this question are often trying to determine whether the IP story is stable enough for scaling. Buyers asking it are often trying to estimate post-closing friction and integration risk.
8. Could Any Rights Be Lost, Reclaimed, Or Limited Later?
This is one of the less obvious diligence questions, but it can be a major one.
Copyright assets, for example, may be subject to termination rights under U.S. law. The U.S. Copyright Office explains that authors or their heirs can, in certain circumstances, terminate prior grants of transfers or licenses long after the original agreement, allowing them to regain previously granted rights. See the Copyright Office’s notice-of-termination guidance here. For music catalogs, publishing assets, film libraries, and creator-driven businesses, that issue can materially affect long-term value.
Patent rights can also disappear through lapse if maintenance obligations are missed. As the USPTO notes, failure to timely pay required maintenance fees can lead to expiration of the patent. See the USPTO page here.
Trademark rights can narrow or weaken if actual use does not match the registration, if quality control problems undermine licensed use, or if enforcement has been inconsistent.
Licenses may also contain termination triggers tied to insolvency, breach, change of control, territory expansion, minimum performance thresholds, or sanctions compliance. On that last point, sanctions risk sometimes enters diligence when technology, licensing revenue, counterparties, or end users touch restricted jurisdictions or blocked persons. Treasury’s OFAC guidance regularly emphasizes that transactions involving blocked property are prohibited unless authorized, and that risk-based diligence expectations can apply in technology and services contexts. See, for example, Treasury’s sanctions overview in this enforcement-related release here and OFAC FAQ 346 here.
This question is really about durability. Buyers are not just valuing the IP as it exists today. They are valuing how secure the rights remain over time.
9. How Material Is The IP To Revenue, Defensibility, And Deal Value?
The final question sounds more commercial than legal, but it is usually where the diligence findings come together.
A buyer or investor may ask:
- Which products depend on which IP assets?
- What percentage of revenue is tied to licensed, registered, or proprietary assets?
- If one core patent family fell away, what would change?
- How much value depends on trade secrets versus registrations?
- Are customer contracts, channel relationships, or market access tied to the IP position?
Public-company disclosure norms reflect the same basic logic. SEC reporting frameworks often require businesses to discuss material properties, legal proceedings, and risk factors where intellectual property meaningfully affects the enterprise. See the SEC’s general disclosure framework and filing materials here.
For founders, this is where IP diligence can feel personal because the conversation shifts from “we built something valuable” to “show exactly how the legal rights support the economics.” But for transactions, that is the whole point. If IP is a core asset, the market tends to ask for evidence, continuity, and defensibility, not just a narrative.
That is also why diligence findings often change transaction structure rather than simply “passing” or “failing” the deal. The result may be:
- a holdback or escrow
- special indemnities
- pre-closing cleanup covenants
- consent requirements
- price adjustments
- carve-outs for disputed assets
- post-closing remediation plans
Why These Questions Matter More Than Founders Expect
When founders hear “IP diligence,” many picture a checklist. In reality, buyers and investors are often testing a broader thesis: is this company’s moat legally real, operationally protected, and transferable in a transaction?
That is why a portfolio can look impressive in a pitch deck and still raise concern in diligence. Ten filed patents may matter less than one enforceable patent family with clean ownership, timely maintenance, and direct product relevance. A brand may look strong in the market and still create concern if the registrations are inconsistent, licensed loosely, or held by the wrong entity. A software platform may be commercially mature and still face friction if old contractor paperwork leaves authorship questions unresolved.
The practical takeaway is not that every defect is fatal. Many are fixable. Some are ordinary. Some simply change the negotiation. But once IP becomes central to valuation, ordinary sloppiness tends to become deal risk.
Final Thoughts
When IP is a core asset, buyers and investors usually circle back to the same themes: ownership, control, validity, encumbrances, use rights, confidentiality, disputes, durability, and materiality. Those nine questions may look legal on the surface, but they are really questions about whether the asset at the center of the deal is as reliable as everyone hopes it is.
For companies preparing for a financing, sale, acquisition, or strategic partnership, early legal review often helps surface issues while there is still time to organize assignments, fix recordation gaps, review licenses, and understand where transaction leverage may be affected.
Visit ReferU.AI to get matched with an attorney who has demonstrable experience in cases like yours — for free.
